Fatty liver diseases (FLD) have become a significant health concern worldwide, affecting millions. The two most common types of FLD are non-alcoholic fatty liver disease (NAFLD) and alcoholic-associated liver disease (ALD). NAFLD is associated with obesity, insulin resistance, and metabolic syndrome, while ALD is caused by excessive alcohol consumption.
GE Healthcare to buy radiopharmaceutical firm Nihon Medi-Physics
Dive Brief: GE Healthcare will acquire Nihon Medi-Physics (NMP), a Tokyo-based radiopharmaceutical firm, by buying the remaining 50% stake from parent Sumitomo Chemical, the companies
December 3, 2024